Abstract
Cancer gene therapy is considered a very viable approach for the treatment of cancer. The basic idea is to introduce the therapeutic gene, often in the form of a foreign cDNA, into the cancer or other appropriate target cells. For gene delivery purposes, several viral and non-viral vectors have been described. One vector that has become very popular for the purpose of cancer gene therapy is adenovirus. Main reasons are that the recombinant adenoviruses expressing the foreign therapeutic genes can be easily generated, and that the infection of the target cells with the recombinant adenoviruses produces large quantities of the therapeutic proteins. The review describes the basic characteristics and the molecular biology of adenoviruses. This review further describes various methods to generate the recombinant adenoviruses. These include the methods to generate the first generation adenoviruses (E1 deleted), up to the most recently used gutless viruses (with complete viral deletions). A critical compari son of the advantages and disadvantages of various methods is also described. The review also describes the use of adenoviruses which selectively replicate in cancer cells. The review further describes the various approaches for cancer gene therapy currently being exploited. These include the gene replacement strategies using tumor suppressor genes, anti-oncogenes, use of suicide genes, immunomodulation and anti-angiogenesis approaches. An in depth analysis of the pre-clinical data obtained using adenoviral vectors for these cancer gene therapy approaches is also described. The review concludes with a critical discussion of the adenoviruses for cancer gene therapy.
Keywords: adenovirus, adenoviral vector, cancer gene therapy, foreign cdna, viral vector
Current Genomics
Title: Adenoviral Vectors for Cancer Gene Therapy
Volume: 3 Issue: 3
Author(s): Wenli Zhao, Masanobu Kobayashi, Masuo Hosokawa and Prem Seth
Affiliation:
Keywords: adenovirus, adenoviral vector, cancer gene therapy, foreign cdna, viral vector
Abstract: Cancer gene therapy is considered a very viable approach for the treatment of cancer. The basic idea is to introduce the therapeutic gene, often in the form of a foreign cDNA, into the cancer or other appropriate target cells. For gene delivery purposes, several viral and non-viral vectors have been described. One vector that has become very popular for the purpose of cancer gene therapy is adenovirus. Main reasons are that the recombinant adenoviruses expressing the foreign therapeutic genes can be easily generated, and that the infection of the target cells with the recombinant adenoviruses produces large quantities of the therapeutic proteins. The review describes the basic characteristics and the molecular biology of adenoviruses. This review further describes various methods to generate the recombinant adenoviruses. These include the methods to generate the first generation adenoviruses (E1 deleted), up to the most recently used gutless viruses (with complete viral deletions). A critical compari son of the advantages and disadvantages of various methods is also described. The review also describes the use of adenoviruses which selectively replicate in cancer cells. The review further describes the various approaches for cancer gene therapy currently being exploited. These include the gene replacement strategies using tumor suppressor genes, anti-oncogenes, use of suicide genes, immunomodulation and anti-angiogenesis approaches. An in depth analysis of the pre-clinical data obtained using adenoviral vectors for these cancer gene therapy approaches is also described. The review concludes with a critical discussion of the adenoviruses for cancer gene therapy.
Export Options
About this article
Cite this article as:
Zhao Wenli, Kobayashi Masanobu, Hosokawa Masuo and Seth Prem, Adenoviral Vectors for Cancer Gene Therapy, Current Genomics 2002; 3 (3) . https://dx.doi.org/10.2174/1389202023350516
DOI https://dx.doi.org/10.2174/1389202023350516 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Integrating Machine Learning with Genome Science: Pioneering Developments and Future Directions
Integrating machine learning (ML) with genome science is driving transformative advancements in fields such as genomics, personalized medicine, and drug discovery. Genomic data is vast and complex, making traditional analysis methods inadequate for uncovering deep insights. Machine learning, particularly deep learning models like convolutional neural networks (CNNs) and recurrent neural ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Thinking Outside the ‘Block’: Alternative Polymer Compositions for Micellar Drug Delivery
Current Topics in Medicinal Chemistry Postoperative Radiotherapy After Radical Prostatectomy: Adjuvant or Salvage?
Current Cancer Therapy Reviews Qigefang Inhibits Migration, Invasion, and Metastasis of ESCC by Inhibiting Gas6/Axl Signaling Pathway
Recent Patents on Anti-Cancer Drug Discovery Cancer Stem Cell Model in Oral Squamous Cell Carcinoma
Current Stem Cell Research & Therapy Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics
Current Medicinal Chemistry Mouse Mutants of Relaxin, Insulin-Like 3 Peptide and their Receptors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions
Current Medicinal Chemistry A Computational Prediction of Conserved MicroRNA Targets of Ion Channels in Vertebrates
Current Bioinformatics Carbonic Anhydrase IX as a Target for Designing Novel Anticancer Drugs
Current Medicinal Chemistry Erdafitinib as a Novel and Advanced Treatment Strategy of Metastatic Urothelial Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Population Diversity and its Relationship with Infectious and Tumor Diseases
Current Immunology Reviews (Discontinued) Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy
Current Medicinal Chemistry Role of ncRNAs in Development, Diagnosis and Treatment of Human Cancer
Recent Patents on Anti-Cancer Drug Discovery Immune Checkpoint Inhibitors and Neurotoxicity
Current Neuropharmacology Molecular Targets of FTY720 (Fingolimod)
Current Molecular Medicine Recent Progress in Studying Curcumin and its Nano-preparations for Cancer Therapy
Current Pharmaceutical Design Recent Patents on Heat Shock Proteins Targeting Antibodies
Recent Patents on Anti-Cancer Drug Discovery Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry Review on Documented Medicinal Plants used for the Treatment of Cancer
Current Traditional Medicine P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential
CNS & Neurological Disorders - Drug Targets